Free Trial

KalVista Pharmaceuticals (KALV) SEC Filings & 10K Form

KalVista Pharmaceuticals logo
$8.71 +0.06 (+0.69%)
(As of 09:39 AM ET)

Recent KalVista Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/16/2024
6:07 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:08 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:17 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:07 PM
KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/27/2024
7:43 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
7:45 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
3:41 PM
KalVista Pharmaceuticals (Issuer)
Reid Laurence (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:06 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
6:18 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
6:18 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
6:19 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
11:54 AM
Capital World Investors (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
1:34 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13D/A
11/04/2024
3:40 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
11:00 AM
KalVista Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:00 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:05 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:06 PM
KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:07 PM
KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:07 PM
KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:08 PM
KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:08 PM
Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:32 PM
KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:34 PM
KalVista Pharmaceuticals (Issuer)
Piekos Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
7:31 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:39 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:24 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:07 PM
KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/26/2024
6:58 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
7:00 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:13 PM
KalVista Pharmaceuticals (Filer)
Form DEFA14A
08/22/2024
3:17 PM
KalVista Pharmaceuticals (Filer)
Form ARS
08/22/2024
3:08 PM
KalVista Pharmaceuticals (Filer)
Form DEF 14A
08/21/2024
8:25 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
8:25 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
8:26 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:23 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2024
11:15 PM
KalVista Pharmaceuticals (Filer)
Form EFFECT
07/11/2024
3:49 PM
KalVista Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/28/2024
3:21 PM
KalVista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
How to piss off your liberal friends… and profit from it (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
06/10/2024
5:42 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:55 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:57 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:58 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:59 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:34 PM
Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2024
3:35 PM
Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:37 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
3:50 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:38 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
3:35 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13G
02/22/2024
12:22 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13D/A
02/21/2024
8:51 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:41 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:44 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:46 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:48 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:49 PM
KalVista Pharmaceuticals (Subject)
TCG Crossover GP I, LLC (Filed by)
Form SC 13D/A
02/16/2024
3:32 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:21 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:52 PM
KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
4:13 PM
KalVista Pharmaceuticals (Filer)
Form 424B5
02/13/2024
8:11 AM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:20 AM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:23 AM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:06 AM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:08 AM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:55 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
7:30 PM
KalVista Pharmaceuticals (Subject)
Saturn V Capital Management LP (Filed by)
Form SC 13G
02/09/2024
8:16 AM
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
7:11 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:38 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
6:07 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:24 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:02 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:04 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:26 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:57 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
5:05 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:24 PM
KalVista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/08/2024
3:47 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
3:13 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
5:44 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:16 PM
KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
12/27/2023
4:12 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KALV) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners